| Literature DB >> 21572918 |
Ahmed Kablan1, Rudel A Saunders, Maria Szkudlarek-Mikho, Andrew J B Chin, Raul M Bosio, Kazuyuki Fujii, Joseph Shapiro, Khew-Voon Chin.
Abstract
The global increase in the incidence of obesity has emerged as one of the most serious public health risks in recent years. Despite the enormity of the obesity pandemic, there are currently only two FDA-approved therapies for its treatment and these drugs exhibit modest efficacy and have limiting side effects. Prieurianin is a plant limonoid product that deters feeding in insect larvae. We investigated in this study the effects of prieurianin on weight loss and adipogenesis. Our results showed that prieurianin causes weight loss by reducing energy intake in obese mice on high-calorie diet. We also found that prieurianin is anti-adipogenic in cultured preadipocytes and adipocytes by inhibiting proliferation and differentiation of preadipocytes into adipocytes, and induces either dedifferentiation or delipidation of mature adipocytes. Whether prieurianin can potentially be used for obesity treatment in human warrants further investigation.Entities:
Year: 2010 PMID: 21572918 PMCID: PMC3093537 DOI: 10.4172/2155-6156.1000101
Source DB: PubMed Journal: J Diabetes Metab